HopeStage
Back to all studies
CompletedNCT00399698

Risperidone and thinking, movement, and steadiness in children

About this titleRead the official source — NCT00399698
Medication studyAges 4–14United StatesAdjustment disorder
The study in practice

Understand this study

Who was this study for?

Listed age limits: 4 years to 14 years.

Listed locations
ColumbusSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 1999
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
Ohio State University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 4 Years to 14 Years
Official registry ID
NCT00399698
Official title
Show the full official title

Effects of Risperidone on Cognitive-Motor Performance and Motor Movements in Chronically Medicated Children

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Columbus

Registry details
Registry conditions (original wording)

Oppositional Defiant Disorder; Conduct Disorder; Attention Deficit/Hyperactivity Disorder (ADHD); Intermittent Explosive Disorder; Impulse-Control Disorders; Adjustment Disorder; Bipolar Disorder; Pervasive Developmental Disorder

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ohio State University, a university.

Did this study involve medication?

Yes. The study involved medication, including Risperdal.

Who was this study for?

Listed age limits: 4 years to 14 years.

Want to explore more studies?

Explore studies